Fuller & Thaler Asset Management Inc. Has $129.50 Million Stake in Integer Holdings Co. (NYSE:ITGR)

Fuller & Thaler Asset Management Inc. lowered its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 977,172 shares of the medical equipment provider's stock after selling 4,014 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 2.91% of Integer worth $129,495,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Lord Abbett & CO. LLC grew its holdings in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after acquiring an additional 9,754 shares in the last quarter. Versant Capital Management Inc boosted its position in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after purchasing an additional 183 shares during the last quarter. GAMMA Investing LLC grew its stake in Integer by 36.0% in the fourth quarter. GAMMA Investing LLC now owns 888 shares of the medical equipment provider's stock valued at $118,000 after purchasing an additional 235 shares in the last quarter. Park Avenue Securities LLC increased its position in Integer by 26.0% in the 4th quarter. Park Avenue Securities LLC now owns 4,710 shares of the medical equipment provider's stock worth $624,000 after purchasing an additional 972 shares during the last quarter. Finally, Contravisory Investment Management Inc. raised its stake in shares of Integer by 210.8% during the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider's stock worth $92,000 after purchasing an additional 470 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

Shares of ITGR stock traded down $2.48 during trading hours on Monday, reaching $120.94. 156,637 shares of the company's stock were exchanged, compared to its average volume of 344,710. The business has a fifty day moving average price of $119.58 and a 200-day moving average price of $130.28. The stock has a market capitalization of $4.22 billion, a P/E ratio of 36.11, a P/E/G ratio of 1.72 and a beta of 1.09. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same period in the prior year, the firm earned $1.14 EPS. The business's revenue was up 7.3% on a year-over-year basis. Analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Raymond James boosted their price target on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday. KeyCorp dropped their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a "buy" rating in a research report on Friday. Finally, Benchmark reduced their price target on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Integer presently has a consensus rating of "Moderate Buy" and a consensus target price of $145.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.